Celularity Inc.

NASDAQ: CELUW · Real-Time Price · USD
0.03
-0.00 (-3.23%)
At close: May 01, 2025, 1:38 PM
0.03
0.00%
After-hours: May 01, 2025, 04:00 PM EDT
-3.23%
Bid 0.03
Market Cap 27.38M
Revenue (ttm) 48.2M
Net Income (ttm) -35.05M
EPS (ttm) -0.87
PE Ratio (ttm) -0.04
Forward PE n/a
Analyst n/a
Ask 0.04
Volume 15,848
Avg. Volume (20D) 21,031.417
Open 0.03
Previous Close 0.03
Day's Range 0.03 - 0.04
52-Week Range 0.03 - 0.04
Beta 0.58

About CELUW

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-...

Industry Biotechnology
Sector Healthcare
IPO Date Jul 19, 2021
Employees 120
Stock Exchange NASDAQ
Ticker Symbol CELUW
Full Company Profile
No News article available yet